Immix Biopharma financial statements

임믹스 바이오파머NASDAQ:IMMX · Nasdaq · Healthcare · sector #16
$9.64-4.84%
2026-10-06 close · prelim

Immix Biopharma's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$23M.

Reported results

Immix Biopharma notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q